Clearance and characterization of residual HSV DNA in recombinant adeno-associated virus produced by an HSV complementation system-Reference-Cited by-同舟云学术

Clearance and characterization of residual HSV DNA in recombinant adeno-associated virus produced by an HSV complementation system

Published:2010-07-29 Issue:2 Volume:18 Page:135-144
ISSN:0969-7128
Container-title:Gene Therapy
language:en
Short-container-title:Gene Ther

Author:

Ye G-J,Scotti M M,Liu J,Wang L,Knop D R,Veres G

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/gt2010102.pdf

Reference27 articles.

1. Muzyczka N, Berns KI . Parvoviridae: the viruses and their replication. In: Knipe DM, Howley PM (eds). Fields Virology. Lippincott Williams & Wilkins: Philadelphia, 2001, pp 2327–2359.

2. Jiang H, Pierce GF, Ozelo MC, de Paula EV, Vargas JA, Smith P et al. Evidence of multiyear factor IX expression by AAV-mediated gene transfer to skeletal muscle in an individual with severe hemophilia B. Mol Ther 2006; 14: 452–455.

3. Kaplitt MG, Feigin A, Tang C, Fitzsimons HL, Mattis P, Lawlor PA et al. Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial. Lancet 2007; 369: 2097–2105.

4. Worgall S, Sondhi D, Hackett NR, Kosofsky B, Kekatpure MV, Neyzi N et al. Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA. Hum Gene Ther 2008; 19: 463–474.

5. Brantly ML, Spencer LT, Humphries M, Conlon TJ, Spencer CT, Poirier A et al. Phase I trial of intramuscular injection of a recombinant adeno-associated virus serotype 2 alpha-1 antitrypsin (AAT) vector in AAT-deficient adults. Hum Gene Ther 2006; 17: 1177–1186.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of highly pure rAAV9 vector stocks produced in suspension by PEI transfection or HSV infection reveals striking quantitative and qualitative differences;Molecular Therapy - Methods & Clinical Development;2022-03

2. PCR-Based Analytical Methods for Quantification and Quality Control of Recombinant Adeno-Associated Viral Vector Preparations;Pharmaceuticals;2021-12-24

3. Characterization of recombinant β subunit of human MUC4 mucin (rMUC4β);Scientific Reports;2021-12

4. Detailed Protocol for the Novel and Scalable Viral Vector Upstream Process for AAV Gene Therapy Manufacturing;Human Gene Therapy;2021-08-01

5. Cellular pathways of recombinant adeno-associated virus production for gene therapy;Biotechnology Advances;2021-07